No Data
No Data
Galera Therapeutics | 10-Q: Quarterly report
Express News | Galera Therapeutics Had Cash And Cash Equivalents Of $13.5M Expected To Provide Cash Runway Into Q3 2025
Express News | Galera Therapeutics Q1 2024 GAAP EPS $(0.08) Beats $(0.35) Estimate
Galera Therapeutics Had Cash and Cash Equivalents of $13.5M at March 31 >GRTX
Galera Therapeutics Had Cash and Cash Equivalents of $13.5M at March 31 >GRTX
Galera Therapeutics: Evaluation of Potential Strategic Alternatives Progresses With Goal to Maximize Stockholder Value >GRTX
Galera Therapeutics: Evaluation of Potential Strategic Alternatives Progresses With Goal to Maximize Stockholder Value >GRTX
Express News | Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
Jaguar8 : Huge EPS improvement
TrytosaveabitOP Jaguar8: I know right! Before they got the CRL late last year they were trading above 2.00! They should be back up over that? Grrr hehehe
Jaguar8 TrytosaveabitOP: Hopefully
买跌不追涨 : 股价无反应
TrytosaveabitOP 买跌不追涨: And I don’t expect to see much? Maybe a bit during RMH? But I’m also looking for it to maybe start a overall uptrend eventually? NFA JMO! GL
View more comments...